Physician profile

Lisa A King

Reproductive Endocrinology · Desoto, TX

NPI 1922056043

$587.40

in general payments reported to CMS, 2019-2025

16 companies · $7.91 in 2025

See the full distribution for Reproductive Endocrinology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Lupin INC. $116.93 2019-2020
Abbvie INC. $77.62 2019-2021
Therapeuticsmd, INC. $56.78 2019-2020
Avion Pharmaceuticals $53.35 2019
Pfizer INC. $47.91 2019-2022
Duchesnay USA Incorporated $32.88 2019
Allergan, INC. $31.55 2019
Merck Sharp & Dohme LLC $31.53 2019
Millicent US INC $21.92 2021
Vertical Pharmaceuticals, LLC $20.65 2019
Myovant Sciences INC. $18.46 2021
Organon LLC $17.51 2021-2025 Jada System
Sanofi Pasteur INC. $17.50 2019
Bayer Healthcare Pharmaceuticals INC. $17.04 2019
Amag Pharmaceuticals, INC. $13.31 2020
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Hologic Sales and Service, LLC $12.46 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lisa A King

$587.40

in general payments reported 2019-2025

Years
2019-2025
Top company
Lupin INC.

https://glasscript.com/doctor/359992/lisa-a-king

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.